• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮血管疾病的最新进展

Update on vascular disease in systemic lupus erythematosus.

作者信息

Kao Amy H, Sabatine Janice M, Manzi Susan

机构信息

University of Pittsburgh School of Medicine, Pennsylvania, USA.

出版信息

Curr Opin Rheumatol. 2003 Sep;15(5):519-27. doi: 10.1097/00002281-200309000-00001.

DOI:10.1097/00002281-200309000-00001
PMID:12960475
Abstract

PURPOSE OF REVIEW

Young women with systemic lupus erythematosus have strikingly high rates of coronary heart disease. Current knowledge indicates that atherosclerosis is an active inflammatory and immune-mediated process. Therefore, the chronic inflammation and immune dysregulation characteristic of systemic lupus erythematosus undoubtedly contribute to the accelerated vascular disease seen in these patients. Carefully considering what is known about atherogenesis in the general population will provide clues to unraveling the complexity of why systemic lupus erythematosus and atherosclerosis are linked so frequently.

RECENT FINDINGS

Inflammation is involved in all aspects of atherogenesis from the initial endothelial "response to injury," to foam cell formation leading to the atherosclerotic lesion, to the rupture of the "vulnerable" fibrous cap, resulting in the acute coronary syndrome and potentially in death. The authors review how factors commonly seen in systemic lupus erythematosus or inherent to the underlying disease mechanism may contribute to each of the stages of atherogenesis.

SUMMARY

Our focus on the causes of vascular disease in systemic lupus erythematosus must now include nontraditional risk factors such as immune and inflammatory mediators. With the advent of noninvasive screening tools for atherosclerosis, we are better equipped to measure subclinical vascular disease and associated risk factors, including immune and inflammatory mediators. When considering strategies for preventing premature cardiovascular disease in systemic lupus erythematosus, modifying immune and inflammatory risk factors will likely become a major component of the program in addition to modifying the current traditional risk factors.

摘要

综述目的

患有系统性红斑狼疮的年轻女性患冠心病的几率出奇地高。目前的知识表明,动脉粥样硬化是一个活跃的炎症和免疫介导过程。因此,系统性红斑狼疮所特有的慢性炎症和免疫失调无疑促成了这些患者中出现的血管疾病加速。仔细思考普通人群中已知的动脉粥样硬化发病机制,将为解开系统性红斑狼疮与动脉粥样硬化为何频繁关联的复杂性提供线索。

最新发现

炎症参与动脉粥样硬化发生的各个方面,从最初的内皮细胞 “损伤反应”,到导致动脉粥样硬化病变的泡沫细胞形成,再到 “易损” 纤维帽的破裂,从而导致急性冠状动脉综合征并可能导致死亡。作者回顾了系统性红斑狼疮中常见的因素或潜在疾病机制所固有的因素可能如何促成动脉粥样硬化发生的各个阶段。

总结

我们目前对系统性红斑狼疮血管疾病病因的关注必须包括免疫和炎症介质等非传统风险因素。随着动脉粥样硬化非侵入性筛查工具的出现,我们有更好的条件来测量亚临床血管疾病及相关风险因素,包括免疫和炎症介质。在考虑预防系统性红斑狼疮患者过早发生心血管疾病的策略时,除了改变当前的传统风险因素外,改变免疫和炎症风险因素可能会成为该计划的一个主要组成部分。

相似文献

1
Update on vascular disease in systemic lupus erythematosus.系统性红斑狼疮血管疾病的最新进展
Curr Opin Rheumatol. 2003 Sep;15(5):519-27. doi: 10.1097/00002281-200309000-00001.
2
Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the causes and possible prevention.系统性红斑狼疮患者的动脉粥样硬化加速:病因及可能的预防措施综述
Hong Kong Med J. 2002 Feb;8(1):26-32.
3
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.“不仅……而且……”:系统性红斑狼疮中导致动脉粥样硬化加速和冠心病过早发生的因素
Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18.
4
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.系统性红斑狼疮中动脉粥样硬化加速的患病率及其相关因素
N Engl J Med. 2003 Dec 18;349(25):2399-406. doi: 10.1056/NEJMoa035471.
5
Cardiovascular disease in systemic lupus erythematosus: has the time for action come?系统性红斑狼疮中的心血管疾病:采取行动的时候到了吗?
Curr Opin Lipidol. 2005 Oct;16(5):501-6. doi: 10.1097/01.mol.0000182533.19135.cb.
6
SLE, atherosclerosis and cardiovascular disease.系统性红斑狼疮、动脉粥样硬化与心血管疾病。
J Intern Med. 2005 Jun;257(6):485-95. doi: 10.1111/j.1365-2796.2005.01502.x.
7
Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management.系统性红斑狼疮中的动脉粥样硬化加速:对患者管理的影响。
Curr Opin Rheumatol. 2001 Sep;13(5):341-4. doi: 10.1097/00002281-200109000-00001.
8
[Accelerated atherosclerosis and inflammation in systemic lupus erythematosus].[系统性红斑狼疮中的加速动脉粥样硬化与炎症]
Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(6):470-80. doi: 10.2177/jsci.35.470.
9
Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus.儿童系统性红斑狼疮中的血脂蛋白异常血症与早发性动脉粥样硬化
Curr Rheumatol Rep. 2004 Dec;6(6):425-33. doi: 10.1007/s11926-004-0021-4.
10
[Atherosclerosis in systemic lupus erythematosus].[系统性红斑狼疮中的动脉粥样硬化]
Presse Med. 2014 Oct;43(10 Pt 1):1034-47. doi: 10.1016/j.lpm.2014.01.021. Epub 2014 Sep 5.

引用本文的文献

1
Cardiovascular changes in the NZB/W F1 mouse model of lupus nephritis.狼疮性肾炎NZB/W F1小鼠模型中的心血管变化。
Front Cardiovasc Med. 2023 Jul 24;10:1182193. doi: 10.3389/fcvm.2023.1182193. eCollection 2023.
2
SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis.SARS-CoV-2 感染与系统性红斑狼疮:内皮功能障碍、动脉粥样硬化和血栓形成。
Clin Rheumatol. 2023 Oct;42(10):2691-2702. doi: 10.1007/s10067-022-06497-1. Epub 2023 Jan 9.
3
Systemic lupus erythematosus presenting as right-sided massive pleural effusion with autoimmune hypothyroidism and medium vessel vasculopathy.
以右侧大量胸腔积液为表现的系统性红斑狼疮,伴有自身免疫性甲状腺功能减退症和中等大小血管血管病变。
BMJ Case Rep. 2022 Nov 29;15(11):e251953. doi: 10.1136/bcr-2022-251953.
4
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus.过氧化物酶体增殖物激活受体γ激动剂吡格列酮可改善系统性红斑狼疮的血管和代谢功能障碍。
Ann Rheum Dis. 2022 Oct 12;81(11):1576-1584. doi: 10.1136/ard-2022-222658.
5
Systemic Lupus Erythematosus with Multiple Autoimmune Disease Presented with Extensive Peripheral Gangrene.系统性红斑狼疮合并多种自身免疫性疾病伴广泛外周坏疽。
Case Rep Rheumatol. 2020 Mar 10;2020:8278275. doi: 10.1155/2020/8278275. eCollection 2020.
6
Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.系统性红斑狼疮患者的亚临床动脉粥样硬化及其与疾病活动和损伤指标的关系。
Z Rheumatol. 2015 Aug;74(6):529-32. doi: 10.1007/s00393-014-1473-1.
7
Proximal aortic stiffness is increased in systemic lupus erythematosus activity in children and adolescents.在儿童和青少年系统性红斑狼疮活动期,主动脉近端僵硬度增加。
ISRN Pediatr. 2013 Sep 19;2013:765253. doi: 10.1155/2013/765253. eCollection 2013.
8
Evaluation of vasomotor reactivity in systemic lupus erythematosus patients and its comparison with the control group.系统性红斑狼疮患者血管舒缩反应性的评估及其与对照组的比较。
J Res Med Sci. 2013 Mar;18(Suppl 1):S47-50.
9
Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.I 型干扰素与系统性红斑狼疮患者队列中心血管疾病亚临床标志物相关。
PLoS One. 2012;7(5):e37000. doi: 10.1371/journal.pone.0037000. Epub 2012 May 14.
10
Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.系统性红斑狼疮患者抑郁的心血管疾病相关预测因素。
Arthritis Care Res (Hoboken). 2011 Apr;63(4):542-9. doi: 10.1002/acr.20426.